SEA Gold Pharma Pharmaceutical Import Profile — Turkey (DGFT 2022–2026)

Name: SEA Gold Pharma Pharmaceutical Import Records from India — 4 Products, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

SEA Gold Pharma — Pharmaceutical Importer Profile (2026) | 4 Products, $650.0K Trade | TransData Nexus

SEA Gold Pharma

Pharmaceutical Importer · Turkey · Advanced Antibiotics Focus · $650.0K Total Trade · DGFT Verified

SEA Gold Pharma is a pharmaceutical importer based in Turkey with a total trade value of $650.0K across 4 products in 2 therapeutic categories. Based on 13 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. SEA Gold Pharma sources from 1 verified Indian supplier, with Medcell Pharma accounting for 100.0% of imports.

SEA Gold Pharma — Import Portfolio & Supplier Network

SEA Gold Pharma import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to SEA Gold Pharma?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Medcell Pharma	$799.9K	24	100.0%

SEA Gold Pharma sources from 1 verified Indian supplier across 12 distinct formulations. The sourcing is highly concentrated — Medcell Pharma accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does SEA Gold Pharma Import?

Formulation	Value	Ships
Ceftrorid 1g (ceftriaxone for	$150.0K	3
Isorid (isotretinoin capsules USP 20MG	$125.6K	3
Levorid(levofloxacin tablets USP 500MG	$121.0K	3
Azirid (azithromycin tablets USP 500MG	$111.4K	3
Iburid (ibuprofen oral suspension BP	$107.8K	3
Vomirid (ondansetron injection BP	$106.7K	3
Paxone (ceftriaxone sodium for	$23.6K	1
Pacimox 1000MG (amoxicillin sodium for	$17.7K	1
Paci-medrol(methylprednisolone acetate	$12.2K	1
Pacidex (dexamethasone sodium	$8.5K	1
Pacimox 500MG (amoxicillin sodium for	$8.4K	1
Pacipain (paracetamol & ibuprofen	$7.0K	1

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ceftriaxone	Advanced Antibiotics	$200.0K	4	0.1%	4
2	Azithromycin	Antibiotics	$150.0K	3	0.1%	12
3	Levofloxacin	Antibiotics	$150.0K	3	0.2%	2
4	Ofloxacin	Advanced Antibiotics	$150.0K	3	0.1%	14

SEA Gold Pharma imports 4 pharmaceutical products across 2 categories into Turkey totaling $650.0K.

SEA Gold Pharma — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

SEA Gold Pharma is a pharmaceutical importer and distributor based in Turkey, specializing in the procurement and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company plays a significant role in Turkey's pharmaceutical supply chain by sourcing a diverse range of pharmaceutical products from international markets, particularly India. This strategic sourcing enables SEA Gold Pharma to meet the growing demand for quality medications within Turkey.

The company's operations are characterized by a focus on high-quality pharmaceutical products, ensuring that they adhere to international standards. SEA Gold Pharma's commitment to quality and reliability has established it as a trusted partner in the Turkish pharmaceutical market. By maintaining strong relationships with reputable suppliers, the company ensures a consistent supply of essential medications to meet the needs of healthcare providers and patients across Turkey.

2Distribution Network

SEA Gold Pharma's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products throughout Turkey. The company operates multiple warehouses equipped with advanced logistics capabilities, enabling timely and secure distribution of medications. While specific warehouse locations are not publicly disclosed, the company's infrastructure supports nationwide coverage, ensuring that products reach various regions promptly.

The logistics operations are optimized to handle the complexities of pharmaceutical distribution, including temperature-sensitive products and compliance with regulatory requirements. SEA Gold Pharma's distribution network is integral to its ability to serve a wide range of clients, including hospitals, pharmacies, and healthcare institutions, ensuring that they have access to the necessary medications when needed.

3Industry Role

In Turkey's pharmaceutical supply chain, SEA Gold Pharma functions primarily as a pharmaceutical importer and distributor. The company sources finished pharmaceutical formulations from international markets, particularly India, and distributes them within Turkey. This role is crucial in ensuring the availability of a diverse range of medications, including those not produced domestically. By importing and distributing these products, SEA Gold Pharma contributes to the overall accessibility and affordability of healthcare in Turkey.

SEA Gold Pharma's position as an importer and distributor allows it to bridge the gap between international pharmaceutical manufacturers and the Turkish market. The company's expertise in navigating regulatory requirements and understanding market dynamics enables it to effectively introduce and establish new pharmaceutical products within Turkey. This role is vital in meeting the evolving healthcare needs of the Turkish population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — SEA Gold Pharma

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

SEA Gold Pharma's sourcing strategy exhibits a high degree of concentration, with a total import value of $650,000 USD from India over 13 shipments, all sourced from a single supplier, MEDCELL PHARMA. This indicates a strong reliance on one supplier for its pharmaceutical imports.

The decision to concentrate sourcing with a single supplier can offer benefits such as streamlined logistics, consistent product quality, and potentially better pricing due to bulk purchasing. However, this strategy also introduces risks, including supply chain disruptions if the supplier faces operational challenges or regulatory issues. The absence of alternative suppliers may limit SEA Gold Pharma's ability to mitigate such risks.

The shipment data reveals a consistent pattern of imports from MEDCELL PHARMA, suggesting a stable and ongoing relationship. This stability is crucial for maintaining uninterrupted supply chains. Nonetheless, the lack of diversification in sourcing could pose challenges in adapting to market changes or supplier-specific issues.

2Supply Chain Resilience

SEA Gold Pharma's supply chain resilience is closely tied to its exclusive reliance on MEDCELL PHARMA for pharmaceutical imports. This singular sourcing approach may limit the company's ability to adapt to disruptions, such as production delays or regulatory changes affecting the supplier.

Importing Pharmaceuticals into Turkey — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Turkey

1Regulatory Authority & Framework

The Turkish Medicines and Medical Devices Agency (TMMDA) is the primary regulatory authority overseeing the pharmaceutical sector in Turkey. Operating under the Ministry of Health, the TMMDA is responsible for granting marketing authorizations, ensuring product safety and efficacy, and regulating the importation and distribution of pharmaceutical products. The agency's role is crucial in maintaining the integrity and reliability of the Turkish pharmaceutical market.

Key legislation governing pharmaceutical imports includes the Regulation on Licensing of Medicinal Products for Human Use, which outlines the requirements for marketing authorizations and import procedures. Additionally, the Law on Pharmaceutical and Medical Preparations (Law No. 1262) provides the statutory framework for the production, importation, and distribution of pharmaceutical products in Turkey. These regulations ensure that imported pharmaceuticals meet the necessary standards for quality, safety, and efficacy.

2Import Licensing & GMP

Import licensing in Turkey requires that pharmaceutical products obtain a valid marketing authorization from the TMMDA before entering the market. This process involves submitting comprehensive documentation, including product information, manufacturing details, and evidence of Good Manufacturing Practice (GMP) compliance. The TMMDA evaluates these submissions to ensure that imported products meet the required standards.

SEA Gold Pharma — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

SEA Gold Pharma's focus on importing advanced antibiotics and antibiotics indicates a strategic alignment with the therapeutic areas experiencing significant demand in Turkey. The importation of these products suggests a response to the country's healthcare needs, particularly in combating bacterial infections. The market demand for such medications is driven by factors such as the prevalence of infectious diseases, the emergence of antibiotic-resistant strains, and the need for effective treatments in both hospital and outpatient settings.

By concentrating on these therapeutic categories, SEA Gold Pharma positions itself as a key player in addressing critical healthcare challenges in Turkey. The company's product strategy reflects an understanding of the market dynamics and a commitment to providing essential medications that support public health initiatives and improve patient outcomes.

2Sourcing Profile

SEA Gold Pharma's sourcing strategy is centered on importing generic drugs from India, focusing on formulations that are in high demand within Turkey. The company's preference for generic formulations allows it to offer cost-effective alternatives to branded medications, making treatments more accessible to a broader segment of the population. India's well-established pharmaceutical industry, known for its adherence to international quality standards, aligns with SEA Gold Pharma's commitment to quality and reliability.

India's role as a global supplier of generic pharmaceuticals positions it as a strategic partner for SEA Gold Pharma. The country's manufacturing capabilities, coupled with its experience in exporting to diverse markets, make it a valuable source for the company's procurement needs. This sourcing profile enables SEA Gold Pharma to maintain a competitive edge in the Turkish market by

Frequently Asked Questions — SEA Gold Pharma

What products does SEA Gold Pharma import from India?

SEA Gold Pharma imports 4 pharmaceutical products across 2 categories. Top imports: Ceftriaxone ($200.0K), Azithromycin ($150.0K), Levofloxacin ($150.0K), Ofloxacin ($150.0K).

Who supplies pharmaceuticals to SEA Gold Pharma from India?

SEA Gold Pharma sources from 1 verified Indian suppliers. The primary supplier is Medcell Pharma (100.0% of imports, $799.9K).

What is SEA Gold Pharma's total pharmaceutical import value?

SEA Gold Pharma's total pharmaceutical import value from India is $650.0K, based on 13 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does SEA Gold Pharma focus on?

SEA Gold Pharma imports across 2 categories. The largest: Advanced Antibiotics (53.8%), Antibiotics (46.2%).

Get Full SEA Gold Pharma Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.